Announcements Trials

Browse Landscape

Phase

Status

Recruiting 76 Not yet recruiting 20 Active not recruiting 15 Completed 7 Terminated 4 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 25 Magnetic Resonance Spectroscopy 17 Biopsy 15 Cyclophosphamide 6 venetoclax 5 Vincristine 4 Surgical Procedures, Operative 4 Radiotherapy, Intensity-Modulated 4 Nivolumab 4 Etoposide 4 Azacitidine 4 pembrolizumab 3 fludarabine phosphate 3 X-Rays 3 Taxes 3 Radiation 3 Injections 3 Cetuximab 3 trastuzumab deruxtecan 2 fludarabine 2 decitabine and cedazuridine drug combination 2 cemiplimab 2 Tacrolimus 2 Standard of Care 2 Sirolimus 2 Radiotherapy 2 Radiosurgery 2 Prednisone 2 Practice Guidelines as Topic 2 Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Drug Therapy × 90 days × Clear all

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡